The Discipline of Public Health and Primary Care, The Institute of Population Health, Trinity College Dublin, Russell Centre, Tallaght Cross, Dublin, D24 DH74, Ireland.
Usher Institute and SPECTRUM Consortium, University of Edinburgh, Old Medical School, Teviot Place, Edinburgh, EH8 9AG, UK.
Syst Rev. 2022 Jun 2;11(1):111. doi: 10.1186/s13643-022-01922-7.
This systematic review and meta-analysis assessed the effectiveness of smoking cessation interventions among women smokers in low socio-economic status (SES) groups or women living in disadvantaged areas who are historically underserved by smoking cessation services.
A systematic literature search was conducted using MEDLINE (OVID), EMBASE, Cochrane, CINAHL, PsychINFO and Web of Science databases. Eligibility criteria included randomised controlled trials of any smoking cessation intervention among women in low SES groups or living in socio-economically disadvantaged areas. A random effects meta-analysis assessed effectiveness of interventions on smoking cessation. Risk of bias was assessed with the Cochrane Risk of Bias tool. The GRADE approach established certainty of evidence.
A total of 396 studies were screened for eligibility and 11 (6153 female participants) were included. Seven studies targeted women-only. 5/11 tested a form of face-to-face support. A pooled effect size was estimated in 10/11 studies. At end of treatment, two-thirds more low SES women who received a smoking cessation intervention were more likely to stop smoking than women in control groups (risk ratio (RR) 1.68, 95% CI 1.36-2.08, I= 34%). The effect was reduced but remained significant when longest available follow-up periods were pooled (RR 1.23, 95% CI 1.04-1.48, I = 0%). There was moderate-to-high risk of bias in most studies. Certainty of evidence was low.
Behavioural and behavioural + pharmacotherapy interventions for smoking cessation targeting women in low SES groups or women living in areas of disadvantage were effective in the short term. However, longer follow-up periods indicated reduced effectiveness. Future studies to explore ways to prevent smoking relapse in this population are needed.
PROSPERO: CRD42019130160.
本系统评价和荟萃分析评估了针对社会经济地位(SES)较低的女性吸烟者或历来得不到戒烟服务的弱势地区女性的戒烟干预措施的有效性。
使用 MEDLINE(OVID)、EMBASE、Cochrane、CINAHL、PsychINFO 和 Web of Science 数据库进行系统文献检索。纳入标准包括针对 SES 较低的女性或生活在社会经济劣势地区的女性的任何戒烟干预措施的随机对照试验。使用随机效应荟萃分析评估干预措施对戒烟的有效性。使用 Cochrane 风险偏倚工具评估风险偏倚。GRADE 方法确定证据的确定性。
共筛选了 396 项研究以确定其是否符合纳入标准,其中 11 项(6153 名女性参与者)符合纳入标准。其中 7 项研究仅针对女性。11 项研究中有 5 项测试了某种形式的面对面支持。在 10 项研究中估计了 pooled effect size。在治疗结束时,接受戒烟干预的 SES 较低的女性中,有三分之二以上更有可能停止吸烟,而对照组女性则没有(风险比(RR)1.68,95%置信区间(CI)1.36-2.08,I=34%)。当合并最长随访时间时,效果虽然有所降低,但仍然显著(RR 1.23,95%CI 1.04-1.48,I=0%)。大多数研究存在较高的风险偏倚。证据的确定性为低。
针对 SES 较低的女性或弱势地区女性的行为和行为+药物治疗戒烟干预措施在短期内是有效的。然而,更长的随访时间表明效果降低。需要进一步研究以探索防止该人群吸烟复发的方法。
PROSPERO:CRD42019130160。